Yukinori Kurokawa

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Topics

Locally Advanced

Top Venues

Annals of gastroenterological surgery

British journal of cancer

Future oncology (London, England)

Japanese journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, Hiasto Kawakami, Takashi Oshima, Kensei Yamaguchi, Kaori Hino, Motohiro Hirao, Yukinori Kurokawa, Takeshi Kawakami, Masahiro Tsuda, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Kei Muro
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Atsushi Takeno, Masaaki Motoori, Kentaro Kishi, Takeshi Omori, Motohiro Hirao, Toru Masuzawa, Kazumasa Fujitani, Kazuyoshi Yamamato, Yukinori Kurokawa, Yuichiro Doki
Prognostic factors of conversion surgery for stage IV gastric cancer: A multi-institutional retrospective analysis. Annals of gastroenterological surgery 8 (3) (2024)
Atsushi Takeno, Masaaki Motoori, Kentaro Kishi, Takeshi Omori, Motohiro Hirao, Toru Masuzawa, Kazumasa Fujitani, Kazuyoshi Yamamato, Yukinori Kurokawa, Yuichiro Doki
Prognostic factors of conversion surgery for stage IV gastric cancer: A multi-institutional retrospective analysis. Annals of gastroenterological surgery 8 (3) (2024)
Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, Hiasto Kawakami, Takashi Oshima, Kensei Yamaguchi, Kaori Hino, Motohiro Hirao, Yukinori Kurokawa, Takeshi Kawakami, Masahiro Tsuda, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Kei Muro
Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Tomonori Akagi, Hideki Endo, Masafumi Inomata, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, Hiroyuki Yamamoto, Yoshihiro Kakeji, Yuko Kitagawa, Akinobu Taketomi, Masaki Mori
Investigation of the impact of COVID-19 on postoperative outcomes using a nationwide Japanese database of patients undergoing laparoscopic distal gastrectomy and low anterior resection for gastric cancer and rectal cancer. Annals of gastroenterological surgery 8 (3) (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer (2024)
Tomohiro Nishina, Narikazu Boku, Yukinori Kurokawa, Keita Sasaki, Ryunosuke Machida, Takaki Yoshikawa
A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group. Japanese journal of clinical oncology (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Tomonori Akagi, Hideki Endo, Masafumi Inomata, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, Hiroyuki Yamamoto, Yoshihiro Kakeji, Yuko Kitagawa, Akinobu Taketomi, Masaki Mori
Investigation of the impact of COVID-19 on postoperative outcomes using a nationwide Japanese database of patients undergoing laparoscopic distal gastrectomy and low anterior resection for gastric cancer and rectal cancer. Annals of gastroenterological surgery 8 (3) (2024)
Takuro Saito, Yukinori Kurokawa, Kazumasa Fujitani, Ryohei Kawabata, Atsushi Takeno, Jota Mikami, Shunji Endo, Jin Matsuyama, Yusuke Akamaru, Masashi Hirota, Kentaro Kishi, Shinya Urakawa, Kei Yamamoto, Koji Tanaka, Tsuyoshi Takahashi, Mikio Oka, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study. British journal of cancer 130 (7) (2024)
Ryosuke Kita, Yoshitomo Yanagimoto, Hiroshi Imazeki, Eisuke Booka, Takahiro Tsushima, Junki Mizusawa, Keita Sasaki, Haruhiko Fukuda, Yukinori Kurokawa, Hiroya Takeuchi, Ken Kato, Yuko Kitagawa, Narikazu Boku, Takaki Yoshikawa, Masanori Terashima, null null
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG). Japanese journal of clinical oncology (2023)
Naoto Gotohda, Toshirou Nishida, Shinsuke Sato, Masato Ozaka, Yujiro Nakahara, Yoshito Komatsu, Masato Kondo, Haruhiko Cho, Yukinori Kurokawa, Yuko Kitagawa
Re-appraisal of the universal definition of tumor rupture among patients with high-risk gastrointestinal stromal tumors. Annals of gastroenterological surgery 7 (6) (2023)
Tetsuro Toriumi, Masanori Terashima, Junki Mizusawa, Kohei Uemura, Yukinori Kurokawa, Shuji Takiguchi, Yuichiro Doki, Jun Hihara, Hiroshi Imamura, Akinori Takagane, Seiji Ito, Takaki Yoshikawa, Takeshi Sano, Mitsuru Sasako
Association between the antiadhesion membrane and small bowel obstruction after open gastrectomy: A supplemental analysis of the randomized controlled JCOG1001 trial. Annals of gastroenterological surgery 8 (1) (2023)
Tomohira Takeoka, Kazuyoshi Yamamoto, Yukinori Kurokawa, Yasuhiro Miyazaki, Ryohei Kawabata, Takeshi Omori, Hiroshi Imamura, Junya Fujita, Hidetoshi Eguchi, Yuichiro Doki
Comparison of the effects of open and laparoscopic approach on body composition in gastrectomy for gastric cancer: A propensity score-matched study. Annals of gastroenterological surgery 8 (1) (2023)
Junji Kawada, Takuro Saito, Yukinori Kurokawa, Ryohei Kawabata, Atsushi Takeno, Tomohira Takeoka, Yohei Nose, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki, null null
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer. Annals of gastroenterological surgery 8 (2) (2023)
Junji Kawada, Takuro Saito, Yukinori Kurokawa, Ryohei Kawabata, Atsushi Takeno, Tomohira Takeoka, Yohei Nose, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki, null null
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer. Annals of gastroenterological surgery 8 (2) (2023)
Junji Kawada, Takuro Saito, Yukinori Kurokawa, Ryohei Kawabata, Atsushi Takeno, Tomohira Takeoka, Yohei Nose, Hisashi Wada, Hidetoshi Eguchi, Yuichiro Doki, null null
Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer. Annals of gastroenterological surgery 8 (2) (2023)
Masanori Tokunaga, Yukinori Kurokawa, Takeo Fukagawa, Kei Muro, Kohei Shitara, Yasuhiro Kodera, Masanori Terashima
Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery. Annals of gastroenterological surgery 7 (6) (2023)
Yoshitomo Yanagimoto, Yukinori Kurokawa, Yuichiro Doki
Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer. Annals of gastroenterological surgery 7 (5) (2023)
Tetsuro Toriumi, Masanori Terashima, Junki Mizusawa, Kohei Uemura, Yukinori Kurokawa, Shuji Takiguchi, Yuichiro Doki, Jun Hihara, Hiroshi Imamura, Akinori Takagane, Seiji Ito, Takaki Yoshikawa, Takeshi Sano, Mitsuru Sasako
Association between the antiadhesion membrane and small bowel obstruction after open gastrectomy: A supplemental analysis of the randomized controlled JCOG1001 trial. Annals of gastroenterological surgery 8 (1) (2023)
Tomohira Takeoka, Kazuyoshi Yamamoto, Yukinori Kurokawa, Yasuhiro Miyazaki, Ryohei Kawabata, Takeshi Omori, Hiroshi Imamura, Junya Fujita, Hidetoshi Eguchi, Yuichiro Doki
Comparison of the effects of open and laparoscopic approach on body composition in gastrectomy for gastric cancer: A propensity score-matched study. Annals of gastroenterological surgery 8 (1) (2023)
Tadayoshi Hashimoto, Izuma Nakayama, Manabu Ohashi, Junki Mizusawa, Hiroshi Kawachi, Ryosuke Kita, Haruhiko Fukuda, Yukinori Kurokawa, Narikazu Boku, Takaki Yoshikawa, Masanori Terashima
Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer. Future oncology (London, England) (2023)
Hidefumi Shiroshita, Hideki Endo, Masafumi Inomata, Tomonori Akagi, Hiroyuki Yamamoto, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, Hiroaki Miyata, Yoshihiro Kakeji, Yuko Kitagawa, Akinobu Taketomi, Masaki Mori
The clinical impact of COVID-19 on endoscopic surgery in Japan: Analysis of data from the National Clinical Database. Annals of gastroenterological surgery 7 (4) (2023)
Shogen Boku, Hironaga Satake, Takashi Ohta, Seiichiro Mitani, Kentaro Kawakami, Yozo Suzuki, Toshihiko Matsumoto, Tetsuji Terazawa, Eiki Yamazaki, Hiroko Hasegawa, Tatsuki Ikoma, Mamoru Uemura, Toshifumi Yamaguchi, Atsushi Naito, Yasunobu Ishizuka, Yukinori Kurokawa, Daisuke Sakai, Hisato Kawakami, Toshio Shimokawa, Toshimasa Tsujinaka, Takeshi Kato, Taroh Satoh, Yoshinori Kagawa
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer. Future oncology (London, England) (2022)
Tetsuji Terazawa, Takeshi Kato, Masahiro Goto, Katsuya Ohta, Hironaga Satake, Shingo Noura, Yoshinori Kagawa, Hisato Kawakami, Hiroko Hasegawa, Kazuhiro Yanagihara, Tatsushi Shingai, Ken Nakata, Masahito Kotaka, Masayuki Hiraki, Ken Konishi, Shiro Nakae, Daisuke Sakai, Yukinori Kurokawa, Toshio Shimokawa, Toshimasa Tsujinaka, Taroh Satoh
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results. The oncologist (2022)
Yukinori Kurokawa, Yuichiro Doki, Junki Mizusawa, Takaki Yoshikawa, Takanobu Yamada, Yutaka Kimura, Shuji Takiguchi, Yasunori Nishida, Norimasa Fukushima, Haruhiko Cho, Masahide Kaji, Motohiro Hirao, Mitsuru Sasako, Masanori Terashima
Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001). The British journal of surgery (2022)
Yukinori Kurokawa
How can sarcopenia be prevented after gastrointestinal surgery? Annals of gastroenterological surgery 6 (5) (2022)
Yoshitomo Yanagimoto, Yukinori Kurokawa, Yuichiro Doki, Takaki Yoshikawa, Narikazu Boku, Masanori Terashima
Surgical and perioperative treatment strategy for resectable esophagogastric junction cancer. Japanese journal of clinical oncology 52 (5) (2022)
Takaomi Hagi, Yukinori Kurokawa, Junki Mizusawa, Takeo Fukagawa, Hitoshi Katai, Takeshi Sano, Kazunari Misawa, Norimasa Fukushima, Yasuyuki Kawachi, Mitsuru Sasako, Takaki Yoshikawa, Masanori Terashima
Impact of tumor-related factors and inter-institutional heterogeneity on preoperative T staging for gastric cancer. Future oncology (London, England) 18 (20) (2022)
Yukinori Kurokawa, Tomono Kawase, Atsushi Takeno, Haruna Furukawa, Ryo Yoshioka, Takuro Saito, Tsuyoshi Takahashi, Toshio Shimokawa, Hidetoshi Eguchi, Yuichiro Doki
Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S-1 for clinical stage III gastric or esophagogastric junction adenocarcinoma. Annals of gastroenterological surgery 7 (2) (2022)
Yukinori Kurokawa, Tomono Kawase, Atsushi Takeno, Haruna Furukawa, Ryo Yoshioka, Takuro Saito, Tsuyoshi Takahashi, Toshio Shimokawa, Hidetoshi Eguchi, Yuichiro Doki
Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S-1 for clinical stage III gastric or esophagogastric junction adenocarcinoma. Annals of gastroenterological surgery 7 (2) (2022)
Hidefumi Shiroshita, Masafumi Inomata, Shigeo Akira, Hiroomi Kanayama, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Hiroki Uchida, Yosuke Seki, Satoshi Ieiri, Masayuki Iwazaki, Yukio Sato, Kaoru Kitamura, Minoru Tabata, Hiromitsu Mimata, Hiroshi Takahashi, Tetsuji Uemura, Tomonori Akagi, Fuminori Taniguchi, Akira Miyajima, Makoto Hashizume, Sumio Matsumoto, Seigo Kitano, Masahiko Watanabe, Yoshiharu Sakai
Current Status of Endoscopic Surgery in Japan: The 15th National Survey of Endoscopic Surgery by the Japan Society for Endoscopic Surgery. Asian journal of endoscopic surgery 15 (2) (2021)
Hiroshi Imamura, Jin Matsuyama, Kazuhiro Nishikawa, Shunji Endo, Tomono Kawase, Yutaka Kimura, Junichi Fukui, Junji Kawada, Yukinori Kurokawa, Kazumasa Fujitani, Daisuke Sakai, Hiasto Kawakami, Toshimasa Tsujinaka, Toshio Shimokawa, Yoshihiro Matsubara, Taroh Satoh, Hiroshi Furukawa, null null
Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S-1 chemotherapy after gastrectomy: A multicenter, open-label, single-arm, prospective phase II study (OGSG1108). Annals of gastroenterological surgery 5 (6) (2021)
Masashi Hirota, Tsuyoshi Takahashi, Yurina Saito, Ryohei Kawabata, Rie Nakatsuka, Hiroshi Imamura, Masaaki Motoori, Yoichi Makari, Atsushi Takeno, Kentaro Kishi, Shinichi Adachi, Hiromichi Miyagaki, Yukinori Kurokawa, Makoto Yamasaki, Hidetoshi Eguchi, Yuichiro Doki
Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials. Annals of gastroenterological surgery 5 (6) (2021)
Yutaka Kimura, Jota Mikami, Makoto Yamasaki, Motohiro Hirao, Hiroshi Imamura, Junya Fujita, Atsushi Takeno, Jin Matsuyama, Kentaro Kishi, Takafumi Hirao, Hiroki Fukunaga, Koichi Demura, Yukinori Kurokawa, Shuji Takiguchi, Hidetoshi Eguchi, Yuichiro Doki
Comparison of 5-year postoperative outcomes after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: Results from a multi-institutional randomized controlled trial. Annals of gastroenterological surgery 5 (1) (2020)
Tomoki Makino, Makoto Yamasaki, Koji Tanaka, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Masaaki Motoori, Yutaka Kimura, Kiyokazu Nakajima, Masaki Mori, Yuichiro Doki
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review. Annals of gastroenterological surgery 3 (2) (2018)
Yosuke Mukai, Yukinori Kurokawa, Shuji Takiguchi, Masaki Mori, Yuichiro Doki
Are treatment outcomes in gastric cancer associated with either hospital volume or surgeon volume? Annals of gastroenterological surgery 1 (3) (2017)